[Federal Register Volume 88, Number 171 (Wednesday, September 6, 2023)]
[Notices]
[Page 60961]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19157]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Studies of von Willebrand Disease.
    Date: October 3, 2023.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Michael P. Reilly, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 208-Z, Bethesda, MD 20892, (301) 827-7975, 
[email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Early Phase Clinical Trials (R61/R33).
    Date: October 18, 2023.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Manoj K. Valiyaveettil, Ph.D., Scientific Review 
Officer, Blood & Vascular Branch, Office Scientific Review, Division 
of Extramural Research Activities (DERA), National Institute of 
Health, National Heart, Lung, and Blood Institute, Bethesda, MD 
20817, (301) 402-1616, [email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Clinical Trials SEP (UG3, U24, R61).
    Date: October 26, 2023.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085, 
[email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; NHLBI Biorepository: Scientific 
Opportunities for Exploratory Research (R21).
    Date: October 27, 2023.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Sun Saret, Ph.D., Scientific Review Officer, 
Office of Scientific Review/DERA, National Heart, Lung, and Blood 
Institute, National Institutes of Health, 6705 Rockledge Drive, Room 
208-S, Bethesda, MD 20892, (301) 435-0270), [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: August 31, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-19157 Filed 9-5-23; 8:45 am]
BILLING CODE 4140-01-P